Circular RNA vaccine induces potent T cell responses
Proceedings of the National Academy of Sciences · 16.05.2023 · 120 (20)
DOI: 10.1073/pnas.2302191120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 08.05.2023. Verfasst von Laura Amaya und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305. Hauptthemen laut MEDLINE: RNA, Circular, Immunization. Die Arbeit wurde bisher 182-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, HHS | NIH | National Cancer Institute.
Abstract (Originalsprache)
Circular RNAs (circRNAs) are a class of RNAs commonly found across eukaryotes and viruses, characterized by their resistance to exonuclease-mediated degradation. Their superior stability compared to linear RNAs, combined with previous work showing that engineered circRNAs serve as efficient protein translation templates, make circRNA a promising candidate for RNA medicine. Here, we systematically examine the adjuvant activity, route of administration, and antigen-specific immunity of circRNA vaccination in mice. Potent circRNA adjuvant activity is associated with RNA uptake and activation of myeloid cells in the draining lymph nodes and transient cytokine release. Immunization of mice with engineered circRNA encoding a protein antigen delivered by a charge-altering releasable transporter induced innate activation of dendritic cells, robust antigen-specific CD8 T cell responses in lymph nodes and tissues, and strong antitumor efficacy as a therapeutic cancer vaccine. These results highlight the potential utility of circRNA vaccines for stimulating potent innate and T cell responses in tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Personal Dynamic Regulomes, Stanford University, Stanford, CA 94305.
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305.
- Institute for Immunity, Transplantation and Infection, Stanford University, Stanford, CA 94305.
- Department of Chemistry, Stanford University, Stanford, CA 94305.
- Department of Chemical and Systems Biology, Stanford University, Stanford, CA 94305.
- HHMI, Stanford University, Stanford, CA 94305.
ORCID-Profile: Laura Amaya, Lilit Grigoryan, Paul A Wender, Howard Y Chang
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- HHS | NIH | National Cancer Institute
- Emerson Collective
- Parker Institute for Cancer Immunotherapy
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- Bill and Melinda Gates Foundation
- Howard Hughes Medical Institute
Zitieren
APA
Amaya, L., Grigoryan, L., Li, Z., Lee, A., Wender, P. A., Pulendran, B., & Chang, H. Y. (2023). Circular RNA vaccine induces potent T cell responses. Proceedings of the National Academy of Sciences, 120(20). https://doi.org/10.1073/pnas.2302191120
Vancouver
Amaya L, Grigoryan L, Li Z, Lee A, Wender PA, Pulendran B, et al. Circular RNA vaccine induces potent T cell responses. Proceedings of the National Academy of Sciences. 2023;120(20). doi:10.1073/pnas.2302191120
BibTeX
@article{Amaya2023,
author = {Amaya, Laura and Grigoryan, Lilit and Li, Zhijian and Lee, Audrey and Wender, Paul A and Pulendran, Bali and Chang, Howard Y},
title = {Circular RNA vaccine induces potent T cell responses},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {20},
doi = {10.1073/pnas.2302191120}
}
EUVIMED